Fwd: IMPORTANT - New Study Linking Thimerosal-Containing Hepatitis B Vaccine ...

[Guest guest]

From: mgeier@...Sent: 11/10/2010 1:20:59 A.M. Eastern Standard TimeSubj: IMPORTANT - New Study Linking Thimerosal-Containing Hepatitis B Vaccine & Autism

Dear Everyone,

Please, find attached to this email a newly published study, "Hepatitis B Vaccination of Male Neonates and Autism Diagnosis, NHIS 1997-2002" by epidemiological investigators from Stony Brook University Medical Center, Health Sciences Center, State University of New York at Stony Brook in the most recent issue of the peer-reviewed Journal of Toxicology and Environmental Health, Part A saved as Published - Hepatitis B Vaccination & Autism 1997-2002.pdf in Adobe Acrobat format.

In this new study, the investigators examined the association between Thimerosal-containing hepatitis B vaccination of male neonates and autism. The investigators examined data collected by the Centers for Disease Control and Prevention (CDC) as part of the National Health Interview Survey from 1997-2002. The investigators used logistic regression, an epidemiological method of analysis, to estimate the odds for an autism diagnosis associated with neonatal hepatitis B vaccination among boys age 3-17 years, born before 1999 (prior to 1999 almost all doses of hepatitis B vaccine contained Thimerosal added at preservative levels [i.e. 12.5 micrograms mercury per dose]), adjusted for race, maternal education, and two-parent house-hold.

These investigators reported [emphasis added], "Boys vaccinated as neonates had three-fold greater odds for autism diagnosis compared to boys never vaccinated or vaccinated after the first month of life...Findings suggest that U.S. male neonates vaccinated with hepatitis B vaccine prior to 1999 (from vaccination record) had a three-fold higher risk for parental report of autism diagnosis compared to boys not vaccinated as neonates during that same time period."

Finally, it is important to consider the results observed in from the aforementioned study in the context of a recently published peer-reviewed study, "Thimerosal Exposure in Infants and Neurodevelopmental Disorders: An Assessment of the Computerized Medical Records in the Vaccine Safety Datalink" in the Journal of the Neurological Sciences by epidemiological investigators, in part, from the Washington University School of Public Health that examined the relationship between mercury exposure from Thimerosal-containing childhood vaccines and neurodevelopmental disorders attached to this email saved as Published Thimerosal Exposure in Infants & NDs - Assessment of the VSD1.pdf in Adobe Acrobat Format.

The study evaluated possible associations between neurodevelopmental disorders and exposure to mercury from Thimerosal-containing vaccines by examining the automated Vaccine Safety Datalink (VSD). A total of 278,624 subjects were identified in birth cohorts from 1990–1996 that had received their first oral polio vaccination by 3 months of age in the VSD. The birth cohort prevalence rate of medically diagnosed International Classification of Disease, 9th revision (ICD-9) specific neurodevelopmental disorders were calculated. Exposures to mercury from Thimerosal-containing childhood vaccines were calculated by birth cohort for specific exposure windows from birth-7 months and birth-13 months of age. Poisson regression analysis was used to model the association between the prevalence of outcomes and Hg doses from Thimerosal-containing childhood vaccines.

These investigators reported [emphasis added], "Consistent significantly increased rate ratios were observed for autism, autism spectrum disorders, tics, attention deficit disorder, and emotional disturbances with mercury exposure from Thimerosal-containing vaccines." Further, these investigators observed about a three-fold higher risk for autism following additional mercury exposure from Thimerosal-containing vaccines.

It is now apparent that multiple investigators using several different datasets collected by the CDC are consistently finding a significant link between the administration of Thimerosal-containing childhood vaccines and the risk of child being diagnosed with autism in large population epidemiological studies of many thousands of children. It is important to remember that these aforementioned studies build upon an extensive body of hundreds of studies in tissue culture, animal models, and clinical case-series of children that have repeatedly found a significant association between mercury exposure and autism.

Sincerely,

Geier